PRRT2 and familial pancreatic carcinoma: In our previous studies, we observed that inhibition of PP2A in pancreatic cancer cells resulted in phosphorylation of multiple substrates, including extracellular signal-related kinase (ERK), JNK, IκB kinase (IKK), protein kinase C (PKC), and β-catenin.